Orlistat, a potent inhibitor of gastric and pancreatic lipases, is now the only medication approved for clinical use to aid weight loss, and the only anti-obesity medicine that does not act on the central nervous system or enter the bloodstream [9]. Here, PNLIP is linked to obesity due to melanocortin 4 receptor deficiency.